Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02879760
Title Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Turnstone Biologics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Tom Baker Cancer Centre Calgary Alberta T2N 4N2 Canada Details
Moncton Hospital Moncton New Brunswick E1C 6Z8 Canada Details
Juravinski Cancer Centre Hamilton Ontario L8V 5C2 Canada Details
Kingston General Hospital Kingston Ontario K7L 2V7 Canada Details
Ottawa Hospital Research Institute Ottawa Ontario K1H 8L6 Canada Details
University Health Network Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field